Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Bridge Bio Pharma, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$27.35 - $40.45 $7,329 - $10,840	-268 Reduced 4.38%	5,845 $180,000
Q4 2023 Feb 08, 2024	SELL	$24.02 - $43.89 $220,407 - $402,734	-9,176 Reduced 60.02%	6,113 $246,000
Q3 2023 Nov 07, 2023	BUY	$16.89 - $35.01 $12,160 - $25,207	720 Added 4.94%	15,289 $403,000
Q2 2023 Aug 09, 2023	SELL	$13.29 - $18.01 $86,039 - $116,596	-6,474 Reduced 30.77%	14,569 $250,000
Q1 2023 May 08, 2023	BUY	$7.17 - $18.55 $12,181 - $31,516	1,699 Added 8.78%	21,043 $348,000
Q4 2022 Feb 07, 2023	SELL	$6.74 - $11.52 $37,299 - $63,751	-5,534 Reduced 22.24%	19,344 $147,000
Q3 2022 Nov 01, 2022	BUY	$7.94 - $12.36 $12,807 - $19,936	1,613 Added 6.93%	24,878 $247,000
Q2 2022 Aug 04, 2022	BUY	$5.21 - $12.14 $121,210 - $282,437	23,265 New	23,265 $211,000

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

Kohlberg Kravis Roberts & Co. L.P. New York, NY

25.3M
Shares

$735 Million
35.94% of portfolio
Viking Global Investors LP

25.1M
Shares

$731 Million
2.47% of portfolio
Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$413 Million
0.01% of portfolio
Black Rock Inc. New York, NY

12.4M
Shares

$362 Million
0.01% of portfolio
Aisling Capital Management LP New York, NY

6.07M
Shares

$176 Million
63.58% of portfolio

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account